Prevail Therapeutics

Prevail Therapeutics

Prevail Therapeutics

Prevail Therapeutics, Inc is an emerging biotech company based in New York City that is developing therapeutics for brain disorders such as Parkinson's disease.
Type
B2c
Founded
2017
Raised
$75M
Follow us
Alexa global traffic share
Latest funding
$75,000,000
Venture capital (Series A) - 2018
Adage Capital Management RA Capital Management OrbiMed +6
Team Size
2
Employees
$75,000,000 Venture capital (Series A)
Xconomy , FinSMEs

Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech

Health Funding Science